Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.

Cellular and molecular neurobiology - 1 Apr 2022

Xu Jie, Liu Fang, Li Yuntao, Shen Liang

Abstract excerpt

Lower grade gliomas (LGGs) with codeletion of chromosomal arms 1p and 19q (1p/19 codeletion) have a favorable outcome. However, its overall survival (OS) varies. Here, we established an immune signature associated with 1p/19q codeletion for accurate prediction of prognosis of LGGs. The Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) databases with RNA sequencing and corresponding clinical...

Topics

Brain Neoplasms
Glioma
Humans
Isocitrate Dehydrogenase
Mutation
Survival Rate

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32894375
DOI: 10.1007/s10571-020-00959-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.PMID 32894375Read ↗

A 1p/19q Codeletion Associated Immune Signature for Predicting Lower Grade Glioma PrognosisSemantic proximity Read ↗

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade gliomaSemantic proximity Read ↗

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q CodeletionSemantic proximity Read ↗

Comparison of Low-Grade Gliomas Molecular Features and Survival by 1p/19q Codeletion in The Cancer Genome AtlasSemantic proximity Read ↗

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read ↗

The Prognostic Value of Risk Score Based on Immunogenenomic Landscape Analysis in GliomaSemantic proximity Read ↗

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade gliomaSemantic proximity Read ↗

Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses.Semantic proximity Read ↗

Development of a prognostic model of glioma based on immune‑related genesSemantic proximity Read ↗

Development and Validation of a Novel Prognostic Model for Glioma Based on Immune-Related GenesSemantic proximity Read ↗

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade GliomaSemantic proximity Read ↗

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.